X
20
Dong Bang Future Tech & Life Co., Ltd. Hwaseong-si Kr, based in South Korea, is a pharmaceutical company.
One of their significant offerings is Rivaroxaban, supported by a 'Valid' Certificate of Suitability (CEP) with the number R0-CEP 2021-211 - Rev 00
This Chemical Type CEP, issued on August 21, 2023, remains in force until January 01, 1970, ensuring its reliability within the pharmaceutical industry.
Substance Number 2932 associated with this CEP further emphasizes